In one study, Vimalachandran et al (2005) reported nuclear positivity for RelA in 23 out of 40 (57%) pancreatic cancers as detected by immunohistochemistry on tissue microarrays with an antibody directed against activated RelA. This evidence concerns the gene RELA and familial pancreatic carcinoma.